-+ 0.00%
-+ 0.00%
-+ 0.00%

ARCH Venture Fund XIII Reports Acquisition of $25 Million in Lyell Immunopharma Common Shares

PUBT·11/05/2026 23:37:01
Listen to the news
ARCH Venture Fund XIII Reports Acquisition of $25 Million in Lyell Immunopharma Common Shares
  • ARCH Venture Fund XIII purchased 2,321,262 shares of Lyell Immunopharma common stock at $10.77 per share.
  • The purchase increased the fund’s holdings to 3,747,790 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001012975-26-001013), on November 05, 2026, and is solely responsible for the information contained therein.